501 related articles for article (PubMed ID: 21619903)
1. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung.
Ishitsuka T; Akita H; Harashima H
J Control Release; 2011 Aug; 154(1):77-83. PubMed ID: 21619903
[TBL] [Abstract][Full Text] [Related]
2. A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway.
Mudhakir D; Akita H; Tan E; Harashima H
J Control Release; 2008 Jan; 125(2):164-73. PubMed ID: 18054812
[TBL] [Abstract][Full Text] [Related]
3. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
4. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid.
Hatakeyama H; Akita H; Ito E; Hayashi Y; Oishi M; Nagasaki Y; Danev R; Nagayama K; Kaji N; Kikuchi H; Baba Y; Harashima H
Biomaterials; 2011 Jun; 32(18):4306-16. PubMed ID: 21429576
[TBL] [Abstract][Full Text] [Related]
5. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
Khalil IA; Hayashi Y; Mizuno R; Harashima H
J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid.
Hatakeyama H; Akita H; Kogure K; Oishi M; Nagasaki Y; Kihira Y; Ueno M; Kobayashi H; Kikuchi H; Harashima H
Gene Ther; 2007 Jan; 14(1):68-77. PubMed ID: 16915290
[TBL] [Abstract][Full Text] [Related]
7. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma.
Hatakeyama H; Akita H; Harashima H
Adv Drug Deliv Rev; 2011 Mar; 63(3):152-60. PubMed ID: 20840859
[TBL] [Abstract][Full Text] [Related]
8. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
[TBL] [Abstract][Full Text] [Related]
9. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
[TBL] [Abstract][Full Text] [Related]
10. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA.
Sakurai Y; Hatakeyama H; Sato Y; Akita H; Takayama K; Kobayashi S; Futaki S; Harashima H
Biomaterials; 2011 Aug; 32(24):5733-42. PubMed ID: 21605898
[TBL] [Abstract][Full Text] [Related]
11. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.
Sato Y; Hatakeyama H; Sakurai Y; Hyodo M; Akita H; Harashima H
J Control Release; 2012 Nov; 163(3):267-76. PubMed ID: 23000694
[TBL] [Abstract][Full Text] [Related]
12. Improving in vivo hepatic transfection activity by controlling intracellular trafficking: the function of GALA and maltotriose.
Akita H; Masuda T; Nishio T; Niikura K; Ijiro K; Harashima H
Mol Pharm; 2011 Aug; 8(4):1436-42. PubMed ID: 21598999
[TBL] [Abstract][Full Text] [Related]
13. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.
Kibria G; Hatakeyama H; Harashima H
Int J Pharm; 2011 Jun; 412(1-2):106-14. PubMed ID: 21414394
[TBL] [Abstract][Full Text] [Related]
14. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
15. A new liposome-based gene delivery system targeting lung epithelial cells using endothelin antagonist.
Allon N; Saxena A; Chambers C; Doctor BP
J Control Release; 2012 Jun; 160(2):217-24. PubMed ID: 22079949
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of angiogenesis-targeted peptide and hydrophobized polyethylene glycol conjugate.
Maeda N; Takeuchi Y; Takada M; Namba Y; Oku N
Bioorg Med Chem Lett; 2004 Feb; 14(4):1015-7. PubMed ID: 15013013
[TBL] [Abstract][Full Text] [Related]
17. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue.
Hossen MN; Kajimoto K; Akita H; Hyodo M; Ishitsuka T; Harashima H
J Control Release; 2010 Oct; 147(2):261-8. PubMed ID: 20647023
[TBL] [Abstract][Full Text] [Related]
18. Envelope-type lipid nanoparticles incorporating a short PEG-lipid conjugate for improved control of intracellular trafficking and transgene transcription.
Masuda T; Akita H; Niikura K; Nishio T; Ukawa M; Enoto K; Danev R; Nagayama K; Ijiro K; Harashima H
Biomaterials; 2009 Sep; 30(27):4806-14. PubMed ID: 19520424
[TBL] [Abstract][Full Text] [Related]
19. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method.
Kogure K; Moriguchi R; Sasaki K; Ueno M; Futaki S; Harashima H
J Control Release; 2004 Aug; 98(2):317-23. PubMed ID: 15262422
[TBL] [Abstract][Full Text] [Related]
20. Combination of chondroitin sulfate and polyplex micelles from Poly(ethylene glycol)-poly{N'-[N-(2-aminoethyl)-2-aminoethyl]aspartamide} block copolymer for prolonged in vivo gene transfection with reduced toxicity.
Uchida S; Itaka K; Chen Q; Osada K; Miyata K; Ishii T; Harada-Shiba M; Kataoka K
J Control Release; 2011 Oct; 155(2):296-302. PubMed ID: 21571018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
